{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:04:19Z","timestamp":1794395059033,"version":"4.9.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.054","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T07:30:18Z","timestamp":1123572618000},"page":"75-81","source":"Crossref","is-referenced-by-count":68,"title":["Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Honar","family":"Cherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle B","family":"Konradsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Kalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2005.07.054_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/archsurg.1952.01260020515002","article-title":"Splenic studies","volume":"65","author":"Shumacker","year":"1952","journal-title":"AMA Arch Surg"},{"issue":"11","key":"10.1016\/j.vaccine.2005.07.054_bib2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archinte.137.11.1526","article-title":"Fulminant pneumococcal infections in \u2019normal\u2019 asplenic hosts","volume":"137","author":"Gopal","year":"1977","journal-title":"Arch Intern Med"},{"issue":"17","key":"10.1016\/j.vaccine.2005.07.054_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM197710272971701","article-title":"Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy","volume":"297","author":"Ammann","year":"1977","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0609.1980.tb01311.x","article-title":"Splenectomy and serious infections","volume":"24","author":"Heier","year":"1980","journal-title":"Scand J Haematol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jcp.55.6.472","article-title":"A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland","volume":"55","author":"Kyaw","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2005.07.054_bib6","first-page":"2381","article-title":"Clinical effectiveness of pneumococcal vaccine. Meta-analysis","volume":"45","author":"Hutchison","year":"1999","journal-title":"Can Fam Physician"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.054_bib7","first-page":"128","article-title":"Anti-pneumococcal vaccine: justifications and results","volume":"53","author":"Bacle","year":"1997","journal-title":"Rev Pneumol Clin"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.054_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00005373-199509000-00009","article-title":"Efficacy and safety of pneumococcal revaccination after splenectomy for trauma","volume":"39","author":"Rutherford","year":"1995","journal-title":"J Trauma"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.054_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jinf.2001.0904","article-title":"Risk of infection and death among post-splenectomy patients","volume":"43","author":"Bisharat","year":"2001","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0264-410X(03)00521-8","article-title":"Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia","volume":"22","author":"Torling","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.054_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/00365540050165929","article-title":"Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle-aged and elderly adults","volume":"32","author":"Hedlund","year":"2000","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.054_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0609.1989.tb00327.x","article-title":"Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients","volume":"43","author":"Grimfors","year":"1989","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.054_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0609.1990.tb00426.x","article-title":"A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease","volume":"45","author":"Grimfors","year":"1990","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2796.2004.01312.x","article-title":"A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma","volume":"255","author":"Landgren","year":"2004","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1399-0012.2000.140111.x","article-title":"Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine","volume":"14","author":"Kazancioglu","year":"2000","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.054_bib16","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archinte.146.8.1554","article-title":"Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine","volume":"146","author":"Linnemann","year":"1986","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.054_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139x.2000.00029.x","article-title":"Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics","volume":"13","author":"Rangel","year":"2000","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0609.1989.tb01250.x","article-title":"Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease","volume":"43","author":"Frederiksen","year":"1989","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.054_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1182\/blood.V54.5.1171.1171","article-title":"Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease","volume":"54","author":"Levine","year":"1979","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.054_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1600-0609.1978.tb02462.x","article-title":"Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect","volume":"20","author":"Bjorkholm","year":"1978","journal-title":"Scand J Haematol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.07.054_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428199609067582","article-title":"Treatment of Hodgkin's disease: the Swedish National Care Programme experience","volume":"21","author":"Glimelius","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.vaccine.2005.07.054_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/A:1026551727795","article-title":"Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease","volume":"11","author":"Axdorph","year":"2000","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib23","first-page":"595","article-title":"Parental longevity and survival in elderly patients with Hodgkin's lymphoma","volume":"87","author":"Landgren","year":"2002","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.054_bib24","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1182\/blood-2002-10-3238","article-title":"CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial","volume":"101","author":"Osby","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.054_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1034\/j.1600-0463.2002.100503.x","article-title":"T-cell-rich B-cell lymphoma\u2014diagnostic and therapeutic aspects","volume":"110","author":"Axdorph","year":"2002","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.054_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.thj.6200301","article-title":"Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60\u201375 years of age with multiple myeloma stages II and III","volume":"4","author":"Lundin","year":"2003","journal-title":"Hematol J"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib27","first-page":"353","article-title":"Anti-C-carbohydrate antibodies after pneumococcal vaccination","volume":"90","author":"Pedersen","year":"1982","journal-title":"Acta Pathol Microbiol Immunol Scand [C]"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.054_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib29","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/JCM.38.6.2043-2050.2000","article-title":"An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study","volume":"38","author":"Plikaytis","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.054_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/1097-0142(196910)24:4<709::AID-CNCR2820240408>3.0.CO;2-E","article-title":"The value of laparotomy and splenectomy in the staging of Hodgkin's disease","volume":"24","author":"Glatstein","year":"1969","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib31","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/infdis\/173.6.1347","article-title":"IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response","volume":"173","author":"Rodriguez-Barradas","year":"1996","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.054_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CDLI.4.6.635-638.1997","article-title":"Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines","volume":"4","author":"Petrasch","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.054_bib33","first-page":"20","article-title":"Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age>or=65","volume":"58","author":"Whitney","year":"2003","journal-title":"Geriatrics"},{"key":"10.1016\/j.vaccine.2005.07.054_bib34","unstructured":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997;46(RR-8):1\u201324."},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.054_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies","year":"2002","journal-title":"Clin Med"},{"key":"10.1016\/j.vaccine.2005.07.054_bib36","doi-asserted-by":"crossref","unstructured":"Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ 1996;312(7028):430\u2013434.","DOI":"10.1136\/bmj.312.7028.430"},{"key":"10.1016\/j.vaccine.2005.07.054_bib37","unstructured":"Pneumococcal vaccination for elderly subjects: license extension. Still no proof of clinical efficacy. Prescrire Int 2000;9(48):106\u2013109."},{"issue":"47","key":"10.1016\/j.vaccine.2005.07.054_bib38","first-page":"3309","article-title":"Prevention of pneumococcal infections in the elderly by vaccination","volume":"154","author":"Nielsen","year":"1992","journal-title":"Ugeskr Laeger"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.054_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198009043031003","article-title":"Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine","volume":"303","author":"Broome","year":"1980","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.vaccine.2005.07.054_bib40","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.270.15.1826","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0934-8840(11)80772-3","article-title":"Antibody response to pneumococcal vaccination in the elderly","volume":"275","author":"Konradsen","year":"1991","journal-title":"Zentralbl Bakteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.054_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/515644","article-title":"Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults","volume":"178","author":"Rubins","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.054_bib43","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/513763","article-title":"Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection","volume":"25","author":"Ekdahl","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2005.07.054_bib44","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0264-410X(00)00409-6","article-title":"Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia","volume":"19","author":"Hartkamp","year":"2001","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2005.07.054_bib45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.054_bib46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/mpo.2950110502","article-title":"Antibody response to pneumococcal vaccine in patients with solid tumors and lymphomas","volume":"11","author":"Shildt","year":"1983","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1183\/09031936.01.00084401","article-title":"Pneumococcal vaccination: current and future issues","volume":"18","author":"Ortqvist","year":"2001","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/adc.87.1.18","article-title":"Should the new pneumococcal vaccine be used in high-risk children?","volume":"87","author":"Finn","year":"2002","journal-title":"Arch Dis Child"},{"issue":"25","key":"10.1016\/j.vaccine.2005.07.054_bib49","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.054_bib50","first-page":"145","article-title":"Infections and antibiotic prophylaxis in sickle cell disease","volume":"59","author":"Lepage","year":"2004","journal-title":"Rev Med Liege"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.054_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00277-003-0779-x","article-title":"Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency","volume":"83","author":"de Montalembert","year":"2004","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.054_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archfami.7.2.178","article-title":"Overwhelming postsplenectomy infection in a patient with penicillin-resistant Streptococcus pneumoniae","volume":"7","author":"Machesky","year":"1998","journal-title":"Arch Fam Med"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.054_bib53","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/AAC.48.9.3491-3497.2004","article-title":"Levofloxacin-resistant invasive streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T15:56:46Z","timestamp":1586361406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007309"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}